Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Reducing cirrhosis threat for high-risk drinkers

Reducing cirrhosis threat for high-risk drinkers

Date time 2 September, 2020
News Type News type Media release
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis (scarring of the liver), which causes approximately 300,000 deaths globally each year.

Also found by the researchers in this multi-national GenomALC Consortium–involving QIMR Berghofer Medical Research Institute and the Southern California Institute for Research and Education (SCIRE)–is that susceptibility to cirrhosis among high-risk drinkers is affected by a family history of alcohol-induced liver disease.

“Only a minority of high-risk drinkers, approximately 10-15 percent, actually end up developing alcohol-induced cirrhosis. But the survival time for those individuals who do develop this devastating disease can be as low as 1-2 years,” said Clinical Associate Professor Devanshi Seth, Head of the Centenary Institute Alcoholic Liver Disease Research Program and senior author of the published study.

“The best way to reduce harm from alcohol (including cirrhosis) is by reducing or cutting out alcohol. High-risk drinking is chronic alcohol use above the recommended guidelines that may result in cirrhosis. Unfortunately, individuals may not be aware of the dangers that heavy drinking entails. The aim of our study was to identify risks associated with cirrhosis in heavy drinkers and to gain insights into additional measures that could help in preventing or reducing cirrhosis in patients whose drinking places them at risk,” she said.

Lead author of the study, which was published in the prestigious science journal ‘American Journal of Gastroenterology’, was Dr John Whitfield from QIMR Berghofer Medical Research Institute.

Dr Whitfield says their study found evidence that an increased risk of developing alcohol-induced cirrhosis could be inherited, especially from fathers.

“Our study showed that risk of cirrhosis was significantly increased in individuals if the father was a chronic alcohol user and had died from liver disease. We also found that high-risk drinkers who consumed coffee were less likely to develop cirrhosis, while tea drinking only marginally lowered the risk,” Dr Whitfield said.

Dr Timothy Morgan, co-senior author of the study and researcher at the SCIRE notes that they’ve also been able to show that obesity and diabetes are both independently linked with an increased risk of alcohol-induced cirrhosis. “High-risk drinkers who have diabetes in middle age are particularly likely to progress to cirrhosis,” he said.

Clinical Associate Professor Seth believes that their findings may have major public health consequences. “Measures such as maintaining a healthy bodyweight, intensive treatment of diabetes or pre-diabetic states, and encouragement of coffee consumption may be useful lifestyle interventions to reduce the risk of alcohol-induced cirrhosis for high-risk drinkers.” she said.

The research was funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) a part of the National Institutes of Health (NIH), USA.

Read the full media release here.

Publication: Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.

Themes

  • Inflammation

    Inflammation

Laboratories

  • Seth

Media enquires

For all media and interview enquiries, please contact Alison Mendel

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • New platform to evolve proteins for better therapies

    Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.
    News Type: Media release
    Date 08 May 2025
  • Turning off protein may help prevent liver cancer

    New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.
    News Type: Media release
    Date 16 Apr 2025
  • Event shines spotlight on genetic heart disease in young people

    The Centenary Institute has hosted a community event, titled ‘A Needle in a Haystack: Unlocking the Secrets of Genetic Heart Conditions’. The event aimed to advance understanding of inherited heart disease and sudden cardiac death in young people.
    News Type: Community
    Date 10 Apr 2025
  • Finding answers for sudden cardiac death in young people

    Each week in Australia, up to three young people die suddenly and unexpectedly from sudden cardiac death, often due to an undiagnosed genetic heart condition. These conditions typically go unnoticed until tragedy strikes, leaving families devastated and searching for answers.
    News Type: Media release
    Date 02 Apr 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram